focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 486.00
Ask: 490.50
Change: 2.50 (0.51%)
Spread: 4.50 (0.926%)
Open: 486.00
High: 490.00
Low: 485.00
Prev. Close: 487.50
TET Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update & Notice of Results

10 Apr 2024 07:00

RNS Number : 9365J
Treatt PLC
10 April 2024
 

 

10 April 2024

 

TREATT PLC

("Treatt" or "the Group")

 

Half Year Trading Update and Notice of Results

Solid performance in H1 2024, with sales accelerating in the second quarter and year-on-year profit growth

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, announces the following trading update for the half year ended 31 March 2024 (the "Period").

HIGHLIGHTS:

· Profit before tax and exceptional items (PBTE) expected to be marginally ahead of prior year at c.£7.5m (H1 2023: £7.3m).

· H1 revenue of £72.1m (H1 2023: £76.0m), reflecting a subdued Q1 from the impact of destocking as expected and previously indicated; and an acceleration in Q2, with sales growing by 5.1% (7.7% in constant currency) compared to the same quarter in FY 2023.

· New wins in Premium products and in China, with both areas growing during H1.

· Improved net operating margin of c.11.0% (H1 2023: 10.1%), reflecting embedded cost disciplines and self-help measures

· Net debt unchanged from 30 September 2023 at £10.3m (FY 2023: £10.4m), reflecting higher citrus commodity prices and high receivables at period end from strong March sales; however good cash generation expected in H2 as receivables convert to cash

· Looking to H2, we have a solid sales order book and healthy sales pipeline

· H2 full year PBTE anticipated to be in line with the Board's expectations.

H1 2024 Performance

Revenue for the half year declined by 5.1% (2.7% decline in constant currency) to £72.1m (FY 2023: £76.0m) as anticipated. Q1, which is typically our quietest quarter, saw a decline year on year due to destocking, however sales were 5.1% ahead (7.7% in constant currency) in Q2 as destocking softened, as expected.

Heritage sales declined by 6.0% (constant currency) as citrus customers elected for cheaper alternatives because of sustained high orange oil prices. Despite this, we continue to support our customers with innovative and differentiating solutions. Within Heritage, Synthetic Aroma was up 3.9% (constant currency), which we consider to be reflective of demand returning in this category which was impacted by destocking in FY23.

Our higher margin Premium categories grew 11.6% (constant currency), with multiple wins in Tea in the North American market. Premium is typically H2 weighted, and as such we expect further sales and margin growth in the second half.

In New Markets, China grew 3.3% (constant currency), securing further wins in leading local beverage brands and we have established a broader base of local manufacturing partners. In line with our strategic ambition we have commenced the scale up of our global Treattzest manufacturing capacity, and this product will be relaunched in April.

Balance sheet

The Group ended the half year with net debt of £10.3m (FY 2023: £10.4m). We continue to focus on working capital management and have successfully reduced inventory volume by 5.6% since September 2023 (16.7% lower than the comparable period), offset by higher commodity prices and seasonal build for strategic and premium demand. An increase in receivables reflects the strong finish to the half year trading and we anticipate a reduction in net debt in the second half, in line with Board expectations.

Ryan Govender, Interim CEO, commented:

"Treatt delivered a robust performance in the first half, making good progress in line with our strategic goals. We are particularly pleased with progress in China, where we continued to invest and consolidate our position, and in our higher margin Premium categories where we have a number of active pipeline opportunities. Momentum in the second quarter was strong, and we recorded our highest ever monthly revenue in March.

As we enter the second half, we are encouraged by our solid order book and healthy sales pipeline. The Board continues to expect to report full year PBTE in line with expectations."

Notice of results

Treatt's results for the half year ended 31 March 2024 are expected to be announced on 14 May 2024.

Treatt plc +44 (0)1284 702500

Ryan Govender Interim Chief Executive Officer

Alison Sleight Interim Chief Financial Officer

 

Joint Brokers

Investec Bank Plc +44 (0)20 7597 5970

Patrick Robb

David Anderson

 

Peel Hunt LLP +44 (0) 20 7418 8900

George Sellar

Mike Burke

 

Financial PR

MHP +44(0) 20 3128 8100

Tim Rowntree Treatt@mhpgroup.com

Eleni Menikou 

Catherine Chapman

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFSDSAIAIIS
Date   Source Headline
5th Dec 20164:35 pmRNSBlock listing Interim Review
1st Dec 20162:55 pmRNSVoting Rights and Capital
29th Nov 20167:00 amRNSFinal Results
31st Oct 20164:45 pmRNSDirector/PDMR Shareholding
19th Oct 20162:51 pmRNSDirector/PDMR Shareholding
30th Sep 20167:00 amRNSTrading Update
29th Sep 20161:21 pmRNSTotal Voting Rights
27th Sep 20163:24 pmRNSHolding(s) in Company
22nd Sep 20163:36 pmRNSDirector/PDMR Shareholding
6th Sep 20163:04 pmRNSHolding(s) in Company
5th Sep 201610:41 amRNSHolding(s) in Company
1st Sep 20163:00 pmRNSDirector/PDMR Shareholding
3rd Aug 201611:00 amRNSDirector/PDMR Shareholding
2nd Aug 20169:54 amRNSTR-1: Notification of Major Interest In Shares
19th Jul 20167:00 amRNSUpdate on Earthoil earn-out dispute
15th Jul 201611:57 amRNSDirector/PDMR Shareholding
17th Jun 201612:48 pmRNSDirector/PDMR Shareholding
15th Jun 20163:26 pmRNSDirector/PDMR Shareholding
13th Jun 20163:53 pmRNSDirector/PDMR Shareholding
9th Jun 20165:07 pmRNSDirector/PDMR Shareholding
3rd Jun 20163:05 pmRNSBlock Listing Six Monthly Return
26th May 20165:09 pmRNSDirector/PDMR Shareholding
24th May 201612:09 pmRNSDirector/PDMR Shareholding
20th May 201611:46 amRNSDirector/PDMR Shareholding
17th May 20167:00 amRNSHalf-year Report
13th May 20163:24 pmRNSBoard Appointment
29th Apr 20169:19 amRNSTotal Voting Rights
28th Apr 20162:19 pmRNSDirector/PDMR Shareholding
13th Apr 20168:34 amRNSDirector/PDMR Shareholding
12th Apr 20162:37 pmRNSDirector/PDMR Shareholding
1st Apr 20167:26 amRNSTrading Statement
17th Mar 20168:35 amRNSDirector/PDMR Shareholding
11th Feb 20162:51 pmRNSDirector/PDMR Shareholding
29th Jan 20164:03 pmRNSTotal Voting Rights
29th Jan 20164:01 pmRNSResult of AGM
21st Jan 20169:55 amRNSHolding(s) in Company
12th Jan 20169:48 amRNSBoard Change
7th Jan 201610:47 amRNSDirector/PDMR Shareholding
31st Dec 20157:00 amRNSAnnual Information Update
31st Dec 20157:00 amRNSTotal Voting Rights
23rd Dec 20152:09 pmRNSDirector/PDMR Shareholding
23rd Dec 201512:37 pmRNSDirector/PDMR Shareholding
18th Dec 201512:25 pmRNSDirector/PDMR Shareholding
15th Dec 201510:56 amRNSDirector/PDMR Shareholding
14th Dec 20151:59 pmRNSAnnual Report
10th Dec 201512:53 pmRNSDirector/PDMR Shareholding
8th Dec 20157:10 amRNSPreliminary results announcement
4th Dec 20158:26 amRNSBlock Listing Six Monthly Return
29th Oct 20158:27 amRNSTotal Voting Rights
21st Oct 201510:19 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.